116 related articles for article (PubMed ID: 36456140)
1. Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance Database.
Sato J; Eren T; Murata S; Shimizu T; Uchida M
Anticancer Res; 2022 Dec; 42(12):5917-5925. PubMed ID: 36456140
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Time to Onset and Outcome of Lenalidomide-induced Thrombosis and Embolism Using Spontaneous Reporting Database.
Sato J; Yamamoto N; Kawahara Y; Shimizu T; Uchida M
In Vivo; 2023; 37(3):1246-1252. PubMed ID: 37103089
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance Study.
Kawahara Y; Murata S; Shimizu T; Uesawa Y; Uchida M
In Vivo; 2023; 37(2):955-961. PubMed ID: 36881059
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Lung Toxicity Related to the Treatment With Alectinib Using a Pharmacovigilance Database.
Sato J; Uchida M; Wakabayashi H; Shimizu T
Anticancer Res; 2022 Jun; 42(6):3109-3116. PubMed ID: 35641286
[TBL] [Abstract][Full Text] [Related]
5. Analyses of Ocular Adverse Reactions Associated With Anticancer Drugs Based on the Japanese Pharmacovigilance Database.
Tanaka J; Koseki T; Kondo M; Ito Y; Yamada S
Anticancer Res; 2022 Sep; 42(9):4439-4451. PubMed ID: 36039456
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Adverse Drug Reaction Risk in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Chisaki Y; Aoji S; Yano Y
Biol Pharm Bull; 2017; 40(6):824-829. PubMed ID: 28566626
[TBL] [Abstract][Full Text] [Related]
7. Neurological and related adverse events in immune checkpoint inhibitors: a pharmacovigilance study from the Japanese Adverse Drug Event Report database.
Sato K; Mano T; Iwata A; Toda T
J Neurooncol; 2019 Oct; 145(1):1-9. PubMed ID: 31452071
[TBL] [Abstract][Full Text] [Related]
8. Adverse event profiles of drugs used for treatment of juvenile idiopathic arthritis according to spontaneous reporting system database.
Niinomi I; Oyama S; Inada A; Wakabayashi T; Hirai T; Kambara H; Iida T; Uchida M; Sano Y; Hosohata K
Int J Clin Pharmacol Ther; 2022 Sep; 60(9):402-407. PubMed ID: 35924642
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Durvalumab-induced Lung Toxicity Using a Spontaneous Reporting Database.
Sato J; Nakano K; Shimizu T; Uchida M
Anticancer Res; 2022 Jul; 42(7):3575-3582. PubMed ID: 35790278
[TBL] [Abstract][Full Text] [Related]
10. Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database.
Hasegawa S; Ikesue H; Nakao S; Shimada K; Mukai R; Tanaka M; Matsumoto K; Inoue M; Satake R; Yoshida Y; Goto F; Hashida T; Nakamura M
Pharmacoepidemiol Drug Saf; 2020 Oct; 29(10):1279-1294. PubMed ID: 32869941
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of drugs that most frequently induce acute kidney injury: A pharmacovigilance approach.
Hosohata K; Inada A; Oyama S; Furushima D; Yamada H; Iwanaga K
J Clin Pharm Ther; 2019 Feb; 44(1):49-53. PubMed ID: 30014591
[TBL] [Abstract][Full Text] [Related]
12. Safety concerns reported by consumers, manufacturers and healthcare professionals: A detailed evaluation of opioid-related adverse drug reactions in the FDA database over 15 years.
Andreaggi CA; Novak EA; Mirabile ME; Sampathkumar S; Gray MP; He M; Kane-Gill SL
Pharmacoepidemiol Drug Saf; 2020 Dec; 29(12):1627-1635. PubMed ID: 32851782
[TBL] [Abstract][Full Text] [Related]
13. Disproportionality Analysis of Safety Signals for a Wide Variety of Opioid-Related Adverse Events in Elderly Patients Using the Japanese Adverse Drug Event Report (JADER) Database.
Omoto T; Asaka J; Sakai T; Sato F; Goto N; Kudo K
Biol Pharm Bull; 2021; 44(5):627-634. PubMed ID: 33952819
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance database.
Kanbayashi Y; Uchida M; Kashiwagi M; Akiba H; Shimizu T
Med Oncol; 2022 Sep; 39(12):219. PubMed ID: 36175697
[TBL] [Abstract][Full Text] [Related]
15. Adverse Cutaneous Drug Reactions Associated with Old- and New- Generation Antiepileptic Drugs Using the Japanese Pharmacovigilance Database.
Hosohata K; Inada A; Oyama S; Niinomi I; Wakabayashi T; Iwanaga K
Clin Drug Investig; 2019 Apr; 39(4):363-368. PubMed ID: 30689189
[TBL] [Abstract][Full Text] [Related]
16. Drug-Associated Acute Kidney Injury Identified in the United States Food and Drug Administration Adverse Event Reporting System Database.
Welch HK; Kellum JA; Kane-Gill SL
Pharmacotherapy; 2018 Aug; 38(8):785-793. PubMed ID: 29883524
[TBL] [Abstract][Full Text] [Related]
17. Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database.
Nagai J; Ishikawa Y
PLoS One; 2021; 16(12):e0260980. PubMed ID: 34855908
[TBL] [Abstract][Full Text] [Related]
18. Fatal adverse drug reactions: A worldwide perspective in the World Health Organization pharmacovigilance database.
Montastruc JL; Lafaurie M; de Canecaude C; Durrieu G; Sommet A; Montastruc F; Bagheri H
Br J Clin Pharmacol; 2021 Nov; 87(11):4334-4340. PubMed ID: 33837554
[TBL] [Abstract][Full Text] [Related]
19. Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Ozawa T; Namkoong H; Takaya R; Takahashi Y; Fukunaga K; Enoki Y; Taguchi K; Kizu J; Matsumoto K; Hasegawa N
BMC Infect Dis; 2022 Jun; 22(1):580. PubMed ID: 35768763
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]